期刊文献+

DWI在卵巢交界性肿瘤与Ⅰ期卵巢癌中的鉴别诊断价值 被引量:1

The Value of DWI in Differential Diagnosis of Borderline Ovarian Cancer and Stage Ⅰ Ovarian Cancer
下载PDF
导出
摘要 目的:探讨DWI序列弥散系数(ADC)值在卵巢交界性肿瘤(borderline ovarian tumors,BOTs)与Ⅰ期卵巢癌(malignant epithelial ovarian tumors,MEOTs)中的鉴别诊断价值。方法:分析在本院行多b值DWI序列检查的BOTs患者18例(20病灶)及Ⅰ期MEOTs患者 20例ADC图中实性成分的平均ADC值(ADCmean),对比不同b值条件下ADCmean值的差异,并以术后病理结果为金标准绘制ROC曲线,然后计算其曲线下面积(AUC),对比不同b值对应ADCmean值在BOTs与Ⅰ期MEOTs中的诊断价值。结果:BOTs和MEOTs的ADCmean值均随着b值的上升而下降,并且BOTs和MEOTs不同b值的ADCmean值比较,差异均有统计学意义(P<0.05)。b值为200、600、1 000 s/mm^2时,其AUC分别为0.879、0.890、0.914,当取b值为1 000 s/mm^2时诊断效能最佳,最佳阈值为1.215×10^-3 mm^2/s,诊断的敏感度、特异度、阳性预测值、阴性预测值、准确率分别为90.0%、85.0%、85.7%、89.4%、87.5%。结论:DWI序列ADC值在BOTs与Ⅰ期MEOTs的鉴别诊断中发挥一定价值,当取b值为1 000 s/mm2时诊断效能最佳。 Objective:To explore the value of apperant diffusion coefficient (ADC) value of diffusion-weighted imaging (DWI) sequence in the differential diagnosis of BOTs and stage Ⅰ MEOTs.Method:The average ADC value (ADCmean) from 18 cases (20 lesions) BOTs patients and 20 cases stage Ⅰ MEOTs patients who underwent DWI with multi b-value in our hospital were analyzed,the difference of ADCmean under different b-value conditions was compared,and the ROC curve was drawn with pathology as the gold standard to calculate the area under the curve (AUC),and the diagnostic value of ADCmean corresponding to different b-value in ovarian borderline tumor and stage Ⅰ ovarian cancer was compared.Result:The ADCmean values of both BOTs and MEOTs decreased with the increase of b value,and the differences between the ADCmean values of BOTs and MEOTs with different b values were statistically significant (P<0.05).When the b-values were 200 s/mm2,600 s/mm^2 and 1 000 s/mm2,the AUC was 0.879,0.890 and 0.914 respectively;when the b-value was 1 000 s/mm2,the diagnostic efficiency was the best,the best threshold was 1.215×10^-3 mm^2/s,and the accuracy of the sensitivity specificity were 90.0%,85.0%,85.7%,89.4% and 87.5% respectively.Conclusion:DWI sequence ADC value plays a certain value in the differential diagnosis between BOTs and stage MEOTs,and the diagnostic efficiency is best when the b-value is 1 000 s/mm^2.
作者 王娟婷 曾燕妮 郑秀琼 李燕 王虹壬 彭剑峰 WANG Juanting;ZENG Yanni;ZHENG Xiuqiong;LI Yan;WANG Hongren;PENG Jianfeng(Huadu District People’s Hospital of Guangzhou City,Guangzhou 510800,China;不详)
出处 《中国医学创新》 CAS 2020年第14期42-46,共5页 Medical Innovation of China
基金 广州市花都区科技计划项目(18-HDWS-010)。
关键词 磁共振成像 弥散加权成像 卵巢交界性肿瘤 卵巢癌 Magnetic resonance imaging Diffusion-weighted imaging Borderline ovarian tumors Malignant epithelial ovarian tumors
  • 相关文献

参考文献8

二级参考文献53

  • 1夏爽,祁吉.MR并行采集技术的优势[J].国外医学(临床放射学分册),2006,29(5):348-353. 被引量:18
  • 2Bammer R. Basic principles of diffusion-weighted imaging. Eur J Radiol, 2003, 45: 169-184.
  • 3Mori S, Barker PB. Diffusion magnetic resonance imaging: its principle and applications. Anat Rec, 1999, 257:102-109.
  • 4Luypaert R, Boujraf S, Sourbron S, et al. Diffusion and perfusion MRI: basic physics. Eur J Radiol, 2001, 38: 19-27.
  • 5Stijven S, Gielen E, Bevernage C, et al. Magnetic resonance imaging: value of diffusion-weighted imaging in differentiating benign from malignant breast lesions. Eur J Obstet Gynecol Reprod Biol, 2013, 166: 215-220.
  • 6Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology, 2010, 254: 47-66.
  • 7Wu LM, Xu JR, Gu HY, et al. Usefulness of diffusion-weighted magnetic resonance imaging in the diagnosis of prostate cancer. Acad Radiol, 2012, 19: 1215-1224.
  • 8Som PM, Dillon WP, Fullerton GD, et al. Chronically obstructed sinonasal secretions: observations on T1 and T2 shortening. Radiology, 1989, 172: 515-520.
  • 9Karaarslan E, Arslan A. Diffusion weighted MR imaging in non- infarct lesions of the brain. Eur J Radiol, 2008, 65: 402-416.
  • 10Moteki T, Ishizaka H. Diffusion-weighted EPI of cystic ovarian lesions: evaluation of cystic contents using apparent diffusion coefficients. J Magn Reson Imaging, 2000, 12: 1014-1019.

共引文献168

同被引文献16

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部